AMN Healthcare Services, Inc. (AMN) Q2 2025 Earnings Call Transcript
AMN Healthcare Services, Inc. (NYSE:AMN) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET
Company Participants
Brian M. Scott – CFO & COO
Caroline Sullivan Grace – President, CEO & Director
Randle G. Reece – Senior Director of Investor Relations & Strategy
Conference Call Participants
Albert J. William Rice – UBS Investment Bank, Research Division
Jack Garner Slevin – Jefferies LLC, Research Division
John Trevor Romeo – William Blair & Company L.L.C., Research Division
Kevin Mark Fischbeck – BofA Securities, Research Division
Mark Steven Marcon – Robert W. Baird & Co. Incorporated, Research Division
Tobey O’Brien Sommer – Truist Securities, Inc., Research Division
Operator
Good afternoon, and thank you for standing by. Welcome to AMN Healthcare’s Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Randy Reece, Vice President, Investor Relations. Please go ahead.
Randle G. Reece
Good afternoon, everyone. Welcome to AMN Healthcare’s second quarter 2025 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call.
Remarks we make during this call about future expectations, projections, trends, plans, events or circumstances constitute forward- looking statements. These statements reflect the company’s current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements, including those identified in our most recently filed Forms 10-K and 10-Q, our earnings release and subsequent filings with the SEC. The company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release.
This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly
